Two- and three-year-olds will be offered the vaccine through their GP. Flu is a serious condition that kills, on average, 11,000 people in England each year and hospitalises many more. It could save your life, or someone you love. The flu vaccine nasal spray, FluMist, is an option for vaccination against the flu. Wellington House Nasal flu vaccine is for use in adults up to 49 years old, and children who are at least 2 years old. Find out more about the flu nasal spray and if you should get it. The newest Covid-19 vaccine candidate to start human testing is the first where volunteers won’t get a painful injection. Record numbers offered flu vaccine as those with flu and COVID-19 more likely to die ... Year 7 children will be offered the flu ‘nasal spray’ in schools to reduce community transmission. A child receiving this vaccine may need a repeat dose 1 month after receiving the first vaccine. People with certain medical conditions should not receive the nasal spray flu vaccine.
CanSino said its shot has been safe in trials and has not caused severe side effects. Flu vaccine is produced by private manufacturers, so supply depends on manufacturers. We’ll send you a link to a feedback form. This vaccine works by exposing you to a small dose of the influenza virus, which helps your body to develop immunity to the disease. The vaccine is given as a single spray squirted up each nostril. For the 2020-2021 season, manufacturers have projected they will provide as many as 194 to 198 million doses of influenza vaccine for the U.S. market. You should receive a flu vaccine every year. The spray vaccine was co-developed by researchers at Xiamen University and Hong Kong University with the aid of vaccine maker Beijing Wantai Biological Pharmacy Enterprise, Bloomberg reported. Astrophysicist discusses possibility of life on Venus. The health system is working to provide the free flu vaccine to 30 million people, the highest number on record. The viruses change over time, so new vaccines are made each year. This winter with COVID still circulating, and the increased risk to life if you are ill with both viruses simultaneously, it is even more vital to get the free jab as soon as you can. The flu vaccine is more important than ever, to help reduce transmission of flu and protect the nation from the double threat of flu and COVID-19. The Hill 1625 K Street, NW Suite 900 Washington DC 20006 | 202-628-8500 tel | 202-628-8503 fax. All primary school children and, for the first time, Year 7 children will be offered the flu ‘nasal spray’ in schools to reduce community transmission. It will take only 2 minutes to fill in. With the simultaneous risk of flu and COVID-19, make sure you get your flu jab if you’re eligible, don’t gather in groups larger than 6 and remember ‘Hands Face Space’, so we can look after each other. When it comes to the flu vaccine, the question for almost everyone shouldn't be if you should get it, but how you should get it. The free vaccine is more important than ever to help protect the nation from a double threat this winter. Several types of viruses cause the flu. It is needle-free, which is a big advantage for children, plus the nasal spray is quick, painless and works even better than the injected flu vaccine. London SE1 8UG, Email (Projections may change as the season progresses.)

We use cookies to collect information about how you use GOV.UK. The most vulnerable, including adults aged 65 and over, those with long-term health conditions and pregnant women, will be offered the flu vaccine first through their GP or pharmacy. We use this information to make the website work as well as possible and improve government services. Your immunity will gradually decrease over the 12 months after you receive the influenza virus nasal vaccine. The nasal spray flu vaccine is approved for use in healthy non-pregnant individuals, 2 years through 49 years old. This vaccine will not treat an active infection that has already developed in the body.
Critics are skeptical about the Chinese-made vaccine because it allegedly triggers fewer antibodies than other products currently under trial analysis, Reuters reported.